$91.84
− 0.60− 0.65%
CacheUpdated 18:57May Be Out Of Date
No data
This data isn't available right now.
No data
| Period | Report Date | Surprise | EPS · Forecast | EPS · Actual | Revenue · Forecast | Revenue · Actual |
|---|---|---|---|---|---|---|
| Aug 202608/05/2026 | — | $1.94 | — |
EPS (Earnings Per Share) is the company's quarterly net profit divided by its share count — how much profit a single share produced in that period. Analysts publish an estimate for each quarter, and the surprise is how far the reported figure landed above or below it. Revenue is total sales before profit: the market often sells a company that beats on earnings but misses on revenue, so the two are read together.
Couldn't load data
Balance-sheet ratios aren't available for this company.
It is an automated pre-screen based on the line of business and AAOIFI's widely used financial thresholds; a final judgement rests with your own school of thought and the certification boards that audit the filings.
The interest-income test (5% of revenue) needs a revenue breakdown our free data source doesn't provide, so that criterion isn't screened.
Solventum, spun off from 3M, provides wound care, surgical products and health information systems.
CacheUpdated 23:20May Be Out Of Date
Average close over the last 50, 100 and 200 trading days. The percentage next to it is how far the current price sits from that average.
Industry: Health Care Technology